154 related articles for article (PubMed ID: 35299752)
1. Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review.
Chen N; Ba W; Zhao D; Sheng L; Zhang X
Front Oncol; 2022; 12():816903. PubMed ID: 35299752
[TBL] [Abstract][Full Text] [Related]
2. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report.
Li J; Ren M; Bi F; Chen Y; Li Z
Front Immunol; 2023; 14():1228653. PubMed ID: 37691960
[TBL] [Abstract][Full Text] [Related]
3. Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review.
Lei Y; Zhao S; Jiang M
Front Immunol; 2021; 12():653319. PubMed ID: 34566950
[TBL] [Abstract][Full Text] [Related]
4. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
5. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1.
Agaimy A; Michal M; Hadravsky L; Michal M
Ann Diagn Pathol; 2016 Aug; 23():21-8. PubMed ID: 27402219
[TBL] [Abstract][Full Text] [Related]
6. Interdigitating and follicular dendritic cell sarcomas: a SEER analysis.
Perkins SM; Shinohara ET
Am J Clin Oncol; 2013 Aug; 36(4):395-8. PubMed ID: 22772431
[TBL] [Abstract][Full Text] [Related]
7. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
[TBL] [Abstract][Full Text] [Related]
8. Follicular dendritic cell sarcoma.
Facchetti F; Simbeni M; Lorenzi L
Pathologica; 2021 Oct; 113(5):316-329. PubMed ID: 34837090
[TBL] [Abstract][Full Text] [Related]
9. Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.
Kitagawa S; Hakozaki T; Kitadai R; Hosomi Y
Thorac Cancer; 2020 Jul; 11(7):1927-1933. PubMed ID: 32421224
[TBL] [Abstract][Full Text] [Related]
10. [Clinical pathologic characteristics of extranodal follicular dendritic cell sarcoma].
Cui LF; Zhang JX; Li Z; Gao Y; Lu T; Zhao HY; Zhong DR
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):218-222. PubMed ID: 30917459
[No Abstract] [Full Text] [Related]
11. Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature.
Feng D; Guan Y; Liu M; He S; Zhao W; Yin B; Liang J; Li Y; Wang J
Front Immunol; 2021; 12():608292. PubMed ID: 34135884
[TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
13. Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma.
Shah P; Shah S; Agostino N
Case Rep Oncol; 2020; 13(3):1131-1135. PubMed ID: 33082759
[TBL] [Abstract][Full Text] [Related]
14. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Beck TN; Kudinov AE; Dulaimi E; Boumber Y
BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
[TBL] [Abstract][Full Text] [Related]
15. Follicular dendritic cell sarcoma of the tonsil.
Eun YG; Kim SW; Kwon KH
Yonsei Med J; 2010 Jul; 51(4):602-4. PubMed ID: 20499431
[TBL] [Abstract][Full Text] [Related]
16. Intra-abdominal Follicular Dendritic Cell Sarcoma (FDCS): Series of 18 cases of a rare entity from Pakistan.
Zubair M; Din NU; Arshad S; Minhas K; Idress R; Ahmad Z
Ann Diagn Pathol; 2020 Dec; 49():151595. PubMed ID: 32905993
[TBL] [Abstract][Full Text] [Related]
17. Follicular dendritic cell sarcoma of the tonsil.
Vorsprach M; Kalinski T; Vorwerk U
Pathol Res Pract; 2015 Jan; 211(1):88-91. PubMed ID: 25512260
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcome of a histiocytic sarcoma patient treated with immune checkpoint inhibitor: a case report.
Nguyen LT; Pham GH; Vu PT; Yi HG
Ann Med Surg (Lond); 2023 Dec; 85(12):6274-6278. PubMed ID: 38098600
[TBL] [Abstract][Full Text] [Related]
19. Follicular dendritic cell sarcoma of the tonsil: case report and review of literature.
Bao L; Wang T; Liu M; Xing F
Int J Clin Exp Pathol; 2021; 14(4):493-500. PubMed ID: 33936372
[TBL] [Abstract][Full Text] [Related]
20. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review.
Fonseca R; Yamakawa M; Nakamura S; van Heerde P; Miettinen M; Shek TW; Myhre Jensen O; Rousselet MC; Tefferi A
Am J Hematol; 1998 Oct; 59(2):161-7. PubMed ID: 9766802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
